Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0fccf67a43496d8988fce1cfb940b68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_515ea6246f9ef1572694421d123fe780 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c471d52224f9fe742000d3eb6bfa201d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9986f190d182af2ea299b47795e01ad1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 |
filingDate |
2006-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cebb2586133367b56f89b7c44ffda4d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c1fa501153d40d1e11aa8308a4cd4e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d1bef4d76aba74859e2a112985bc08c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29a2fc5eeac31ac37e820dff4b34d6fd |
publicationDate |
2009-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009131366-A1 |
titleOfInvention |
Use of Amine-Borane Compounds as Anti-Microbial Agents |
abstract |
Use of amine-borane compounds such as amine cyanoboranes and amino carboxy boranes in the treatment of medical conditions associated with pathogenic microorganisms and particularly against drug-resistant microorganisms, in the treatment of fungal and protozoal infections is disclosed. Use of amine-borane compounds for reducing the load of microorganisms in various substrates and products is further disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020365401-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11605535-B2 |
priorityDate |
2005-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |